USA Financial Formulas’s Transmedics TMDX Stock Holding History

USA Financial Formulas’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-348	Closed	-$54.6K	–	357
2024 Q3	$54.6K	Buy	+348	New	+$53.6K	0.01%	218

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

USA Financial Formulas's TMDX Position: Q4 2024 in Review

USA Financial Formulas sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 348 shares — an estimated $54.6K sold.

USA Financial Formulas first reported a position in TMDX in Q3 2024 and held it in 1 quarter. The position peaked at $54.6K in Q3 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

USA Financial Formulas reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
USA Financial Formulas sold 348 Transmedics shares in Q4 2024, an estimated $54.6K.
USA Financial Formulas first reported a position in Transmedics in Q3 2024 and held it in 1 quarter.
USA Financial Formulas's Transmedics position peaked at $54.6K in Q3 2024.
315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on USA Financial Formulas's 13F filing for Q4 2024, filed 14 Jan 2025.